Merck, Moderna claim encouraging melanoma vaccine trial results
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-08-20 00:56 UTC+10:00
Section: mRNA
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, World News, Crime & Justice
--------------------------------------------------------------------
Snippet:
The vaccine, intismeran autogene, showed ‘meaningful improvements’ for skin cancer patients when used with Merck’s Keytruda treatment, the firms say
--------------------------------------------------------------------